MedPath

LETI Pharma GmbH

🇩🇪Germany
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.leti.de

Clinical Trials

4

Active:0
Completed:4

Trial Phases

2 Phases

Phase 2:2
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Phase 3
1 (33.3%)

Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients

Completed
Conditions
Allergic Asthma
Allergic Rhinoconjunctivitis
First Posted Date
2019-02-22
Last Posted Date
2021-03-26
Lead Sponsor
Leti Pharma GmbH
Target Recruit Count
168
Registration Number
NCT03850626
Locations
🇩🇪

Dr. med Andrea Kienle-Gogolok, Bad Schönborn, Germany

Depigoid Birch 5000 Longterm Study in Adults and Adolescents

Phase 3
Completed
Conditions
Sensitization Against Betula Alba (Birch) Pollen
Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma
First Posted Date
2012-09-27
Last Posted Date
2019-01-16
Lead Sponsor
Leti Pharma GmbH
Target Recruit Count
634
Registration Number
NCT01694836
Locations
🇩🇪

Hautarztpraxis, Berlin, Germany

🇩🇪

Klinik und Poliklinik für Dermatologie und Allergologie der Universität, Bonn, Germany

Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Phase 2
Completed
Conditions
Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma
Sensitization Against Phleum Pratense Pollen
Dose-Finding Study
First Posted Date
2012-07-06
Last Posted Date
2013-11-19
Lead Sponsor
Leti Pharma GmbH
Target Recruit Count
308
Registration Number
NCT01634958
Locations
🇩🇪

Hippke, Ear-Nose-Throat specialist, Berlin, Germany

🇩🇪

Zentrum für Rhinologie und Allergie, Wiesbaden, Germany

Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Phase 2
Completed
Conditions
Allergic Rhinitis and/or Rhinoconjunctivitis +- Asthma
Immunotherapy, Allergen
First Posted Date
2010-06-15
Last Posted Date
2011-06-08
Lead Sponsor
Leti Pharma GmbH
Target Recruit Count
344
Registration Number
NCT01144429
Locations
🇩🇪

Dermatology Weber, Augsburg, Germany

🇩🇪

Licca Klinik Dermatologie, Augsburg, Germany

🇩🇪

Allergie-Centrum-Charité, Berlin, Germany

and more 36 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.